Patent · US Active

Fused bicyclic isoxazolines as inhibitors of cholesterol ester transfer protein

US9663534B2 · kind B2 · utility

1Cited by
16References
15Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 12, 2014
Grant dateMay 30, 2017
Priority date—
Expiry dateDec 12, 2034

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D413/14
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Compounds having the structure of Formula I, including pharmaceutically acceptable salts of the compounds, wherein X is (CH2) or O, are CETP inhibitors and are useful for raising HDL-cholesterol, reducing LDL-cholesterol, and for treating or preventing atherosclerosis:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.